{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:12:17Z","timestamp":1787505137988,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12288-022-01612-3","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T10:05:16Z","timestamp":1669889116000},"page":"392-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression Changes of SIRT1 and FOXO3a Significantly Correlate with Oxidative Stress Resistance Genes in AML Patients"],"prefix":"10.1007","volume":"39","author":[{"given":"Sharareh","family":"Mizani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Vazifeh Shiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Bashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Allahbakhshian Farsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"1612_CR1","doi-asserted-by":"crossref","unstructured":"L\u00f6wenberg B, Rowe JM (2016) Introduction to the review series on advances in acute myeloid leukemia (AML). American Society of Hematology Washington, DC. pp 1\u20131","DOI":"10.1182\/blood-2015-10-662684"},{"issue":"1","key":"1612_CR2","first-page":"29","volume":"127","author":"D Grimwade","year":"2016","unstructured":"Grimwade D, Ivey A, Huntly BJ (2016) Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance blood. J Am Soc Hematol 127(1):29\u201341","journal-title":"J Am Soc Hematol"},{"issue":"1","key":"1612_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A et al (2016) Acute myeloid leukaemia. Nat Rev Dis Primers 2(1):1\u201322","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1612_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.exphem.2009.04.002","volume":"37","author":"JL Shipley","year":"2009","unstructured":"Shipley JL, Butera JN (2009) Acute myelogenous leukemia. Exp Hematol 37(6):649\u2013658","journal-title":"Exp Hematol"},{"issue":"3","key":"1612_CR5","first-page":"453","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the european LeukemiaNet. Blood J Am Soc Hematol 115(3):453\u2013474","journal-title":"Blood J Am Soc Hematol"},{"key":"1612_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1590\/S0100-879X2005000700003","volume":"38","author":"JG Scandalios","year":"2005","unstructured":"Scandalios JG (2005) Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 38:995\u20131014","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"1612_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","volume":"82","author":"H Sies","year":"1997","unstructured":"Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol Trans Integr 82(2):291\u2013295","journal-title":"Exp Physiol Trans Integr"},{"issue":"1","key":"1612_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7053","volume":"6","author":"PC Hart","year":"2015","unstructured":"Hart PC et al (2015) MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun 6(1):1\u201314","journal-title":"Nat Commun"},{"issue":"5","key":"1612_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10616-013-9630-y","volume":"66","author":"M Allahbakhshian-Farsani","year":"2014","unstructured":"Allahbakhshian-Farsani M et al (2014) Cytogentic analysis of human dermal fibroblasts (HDFs) in early and late passages using both karyotyping and comet assay techniques. Cytotechnology 66(5):815\u2013822","journal-title":"Cytotechnology"},{"issue":"9","key":"1612_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.111.246488","volume":"110","author":"MF Oellerich","year":"2012","unstructured":"Oellerich MF, Potente M (2012) FOXOs and sirtuins in vascular growth, maintenance, and aging. Circul Res 110(9):1238\u20131251","journal-title":"Circul Res"},{"issue":"1","key":"1612_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12253-018-0536-z","volume":"26","author":"MA Farsani","year":"2020","unstructured":"Farsani MA et al (2020) The expression of interferon gamma (IFN-\u03b3) and interleukin 6 (IL6) in patients with acute lymphoblastic leukemia (ALL). Pathol Oncol Res 26(1):461\u2013466","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"1612_CR12","first-page":"1060","volume":"18","author":"M Mohamadimaram","year":"2019","unstructured":"Mohamadimaram M, Farsani MA, Mirzaeian A (2019) Evaluation of ATG7 and light chain 3 (LC3) autophagy genes expression in AML patients. Iran J Pharm Res IJPR 18(2):1060","journal-title":"Iran J Pharm Res IJPR"},{"issue":"3","key":"1612_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.31557\/APJCP.2019.20.3.705","volume":"20","author":"M Jabari","year":"2019","unstructured":"Jabari M et al (2019) Hypoxia-inducible factor 1-\u0391 (HIF1\u03b1) and vascular endothelial growth Factor-A (VEGF-A) expression in De Novo AML Patients. Asian Pac J Cancer Prev APJCP 20(3):705","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"6","key":"1612_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/ahg.12210","volume":"81","author":"F Salarpour","year":"2017","unstructured":"Salarpour F et al (2017) Evaluation of CCAAT\/Enhancer binding protein (C\/EBP) alpha (CEBPA) and runt-related transcription factor 1 (RUNX1) expression in patients with De Novo Acute myeloid leukemia. Ann Hum Genet 81(6):276\u2013283","journal-title":"Ann Hum Genet"},{"issue":"3","key":"1612_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2141.2009.07749.x","volume":"146","author":"J Wampfler","year":"2009","unstructured":"Wampfler J et al (2009) SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells. Br J Haematol 146(3):337\u2013341","journal-title":"Br J Haematol"},{"issue":"10","key":"1612_CR16","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"C Bradbury","year":"2005","unstructured":"Bradbury C et al (2005) Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19(10):1751\u20131759","journal-title":"Leukemia"},{"issue":"8","key":"1612_CR17","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.bbapap.2010.05.002","volume":"1804","author":"J Yi","year":"2010","unstructured":"Yi J, Luo J (2010) SIRT1 and p53, effect on cancer, senescence and beyond. Biochim et Biophys Acta (BBA)-Proteins Proteom 1804(8):1684\u20131689","journal-title":"Biochim et Biophys Acta (BBA)-Proteins Proteom"},{"issue":"4","key":"1612_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","volume":"15","author":"L Li","year":"2014","unstructured":"Li L et al (2014) SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell 15(4):431\u2013446","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1612_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/leu.2013.264","volume":"28","author":"MV Stankov","year":"2014","unstructured":"Stankov MV et al (2014) Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 28(3):577\u2013588","journal-title":"Leukemia"},{"issue":"6","key":"1612_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bcp.2004.05.041","volume":"68","author":"R Villaa","year":"2004","unstructured":"Villaa R et al (2004) Epigenetic gene silencing in acute promyelocytic leukemia. Biochem Pharmacol 68(6):1247\u20131254","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"1612_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nrm2190","volume":"8","author":"A van der Horst","year":"2007","unstructured":"van der Horst A, Burgering BM (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8(6):440\u2013450","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"1612_CR22","doi-asserted-by":"publisher","first-page":"e73875","DOI":"10.1371\/journal.pone.0073875","volume":"8","author":"YS Hori","year":"2013","unstructured":"Hori YS et al (2013) Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS ONE 8(9):e73875","journal-title":"PLoS ONE"},{"issue":"5","key":"1612_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/onc.2012.83","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z et al (2013) SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells. Oncogene 32(5):589\u2013598","journal-title":"Oncogene"},{"issue":"7","key":"1612_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jnutbio.2011.03.012","volume":"23","author":"JM Yun","year":"2012","unstructured":"Yun JM et al (2012) Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem 23(7):699\u2013705","journal-title":"J Nutr Biochem"},{"issue":"8","key":"1612_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.tcb.2004.07.006","volume":"14","author":"ME Giannakou","year":"2004","unstructured":"Giannakou ME, Partridge L (2004) The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14(8):408\u2013412","journal-title":"Trends Cell Biol"},{"key":"1612_CR26","doi-asserted-by":"crossref","unstructured":"Ding S et al (2015) Redox regulation in cancer stem cells. Oxid Med Cell Longev, 2015","DOI":"10.1155\/2015\/750798"},{"issue":"22","key":"1612_CR27","first-page":"5816","volume":"117","author":"PS Hole","year":"2011","unstructured":"Hole PS, Darley RL, Tonks A (2011) Do reactive oxygen species play a role in myeloid leukemias?\u00a0 Blood J Am Soc Hematol 117(22):5816\u20135826","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"1612_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"P Li","year":"2016","unstructured":"Li P et al (2016) Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells. Sci Rep 6(1):1\u201313","journal-title":"Sci Rep"},{"issue":"1","key":"1612_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-014-0106-5","volume":"33","author":"UK Udensi","year":"2014","unstructured":"Udensi UK, Tchounwou PB (2014) Dual effect of oxidative stress on leukemia cancer induction and treatment. J Exp Clin Cancer Res 33(1):1\u201315","journal-title":"J Exp Clin Cancer Res"},{"key":"1612_CR30","doi-asserted-by":"crossref","unstructured":"Rajeshwari U et al (2013) Oxidative stress and antioxidant status in acute and chronic myeloid leukemia patients. Open J Blood Dis, 2013","DOI":"10.4236\/ojbd.2013.33A004"},{"issue":"12","key":"1612_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery 12(12):931\u2013947","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"1612_CR32","first-page":"42","volume":"127","author":"BJ Wouters","year":"2016","unstructured":"Wouters BJ, Delwel R (2016) Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood J Am Soc Hematol 127(1):42\u201352","journal-title":"Blood J Am Soc Hematol"},{"issue":"13","key":"1612_CR33","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2013.120","volume":"33","author":"M Roth","year":"2014","unstructured":"Roth M, Chen W (2014) Sorting out functions of sirtuins in cancer. Oncogene 33(13):1609\u20131620","journal-title":"Oncogene"},{"issue":"4","key":"1612_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/BF02982641","volume":"77","author":"MJ Farquhar","year":"2003","unstructured":"Farquhar MJ, Bowen DT (2003) Oxidative stress and the myelodysplastic syndromes. Int J Hematol 77(4):342\u2013350","journal-title":"Int J Hematol"},{"issue":"5666","key":"1612_CR35","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303(5666):2011\u20132015","journal-title":"Science"},{"issue":"4","key":"1612_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MOH.0000000000000152","volume":"22","author":"L Li","year":"2015","unstructured":"Li L, Bhatia R (2015) Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Curr Opin Hematol 22(4):324","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"1612_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep07481","volume":"4","author":"X Chen","year":"2014","unstructured":"Chen X et al (2014) High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients. Sci Rep 4(1):1\u201312","journal-title":"Sci Rep"},{"issue":"1","key":"1612_CR38","first-page":"39","volume":"8","author":"K Goudarzipour","year":"2017","unstructured":"Goudarzipour K, Ahmadzadeh A, Mohammadi MH (2017) Changes of AML 1 and P53 tumor suppressor gene expression in patients de novo acute myeloid leukemia. Arch Adv Biosci 8(1):39\u201345","journal-title":"Arch Adv Biosci"},{"issue":"4","key":"1612_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili D, Arden KC (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117(4):421\u2013426","journal-title":"Cell"},{"issue":"2","key":"1612_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","volume":"128","author":"Z Tothova","year":"2007","unstructured":"Tothova Z et al (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128(2):325\u2013339","journal-title":"Cell"},{"key":"1612_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbadis.2011.12.002","volume":"1822","author":"S Miriyala","year":"2012","unstructured":"Miriyala S et al (2012) Manganese superoxide dismutase, MnSOD and its\nmimics. Biochimica et\nBiophysica Acta (BBA)-Molecular Basis of Disease 1822:794\u2013815","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"6802","key":"1612_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/35030140","volume":"407","author":"P Huang","year":"2000","unstructured":"Huang P et al (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407(6802):390\u2013395","journal-title":"Nature"},{"key":"1612_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2015.04.001","volume":"85","author":"A Miar","year":"2015","unstructured":"Miar A et al (2015) Manganese superoxide dismutase (SOD2\/MnSOD)\/catalase and SOD2\/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer. Free Radic Biol Med 85:45\u201355","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1612_CR44","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1038\/cddis.2013.20","volume":"4","author":"S Kamarajugadda","year":"2013","unstructured":"Kamarajugadda S et al (2013) Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death Dis 4(2):e504\u2013e504","journal-title":"Cell Death Dis"},{"issue":"2","key":"1612_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bjc.6604477","volume":"99","author":"B Yeung","year":"2008","unstructured":"Yeung B et al (2008) Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1\/2. Br J Cancer 99(2):283\u2013293","journal-title":"Br J Cancer"},{"issue":"1","key":"1612_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0006-8993(01)02277-6","volume":"900","author":"E R\u00f6hrdanz","year":"2001","unstructured":"R\u00f6hrdanz E et al (2001) The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res 900(1):128\u2013136","journal-title":"Brain Res"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-022-01612-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-022-01612-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-022-01612-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T03:28:03Z","timestamp":1686108483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-022-01612-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s12288-022-01612-3","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}